[go: up one dir, main page]

HK1029272A1 - 用噻唑烷二酮和磺酰脲治療糖尿病 - Google Patents

用噻唑烷二酮和磺酰脲治療糖尿病 Download PDF

Info

Publication number
HK1029272A1
HK1029272A1 HK00106765A HK00106765A HK1029272A1 HK 1029272 A1 HK1029272 A1 HK 1029272A1 HK 00106765 A HK00106765 A HK 00106765A HK 00106765 A HK00106765 A HK 00106765A HK 1029272 A1 HK1029272 A1 HK 1029272A1
Authority
HK
Hong Kong
Prior art keywords
compound
pharmaceutically acceptable
methyl
dione
ethoxy
Prior art date
Application number
HK00106765A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1029272B (zh
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1029272(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1029272A1 publication Critical patent/HK1029272A1/zh
Publication of HK1029272B publication Critical patent/HK1029272B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK00106765.0A 1997-07-18 1998-07-16 用噻唑烷二酮和磺酰脲治疗糖尿病 HK1029272B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
GB9715306.8 1997-07-18
PCT/GB1998/002109 WO1999003476A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (2)

Publication Number Publication Date
HK1029272A1 true HK1029272A1 (zh) 2001-03-30
HK1029272B HK1029272B (zh) 2007-12-07

Family

ID=

Also Published As

Publication number Publication date
BR9810904A (pt) 2000-09-26
SK287823B6 (sk) 2011-11-04
TR200000135T2 (tr) 2000-05-22
AR019331A2 (es) 2002-02-13
ATE366577T1 (de) 2007-08-15
UY25103A1 (es) 2000-12-29
ES2290989T3 (es) 2008-02-16
ID24198A (id) 2000-07-13
WO1999003476A1 (en) 1999-01-28
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
PL338127A1 (en) 2000-09-25
BG64892B1 (bg) 2006-08-31
DK0998291T3 (da) 2007-11-05
CA2297115A1 (en) 1999-01-28
DE69838066D1 (de) 2007-08-23
AU743269B2 (en) 2002-01-24
EP0998291B2 (en) 2011-07-06
EP0998291B1 (en) 2007-07-11
EP0998291A1 (en) 2000-05-10
IL134045A0 (en) 2001-04-30
BG104139A (en) 2000-11-30
NZ520652A (en) 2004-06-25
AP1318A (en) 2004-10-22
AU8448798A (en) 1999-02-10
IN189035B (zh) 2002-12-07
NO20000229D0 (no) 2000-01-17
PL199125B1 (pl) 2008-08-29
CN1264302A (zh) 2000-08-23
CA2297115C (en) 2010-02-23
CZ2000173A3 (en) 2001-05-16
MY138246A (en) 2009-05-29
AP2000001734A0 (en) 2000-03-31
KR20010021948A (ko) 2001-03-15
ES2290989T5 (es) 2011-11-11
NZ515555A (en) 2002-09-27
DK0998291T4 (da) 2011-09-26
MA26522A1 (fr) 2004-12-20
GB9715306D0 (en) 1997-09-24
DE69838066T3 (de) 2012-03-29
ZA986365B (en) 2000-01-17
PT998291E (pt) 2007-10-11
SI0998291T2 (sl) 2011-10-28
HU229119B1 (en) 2013-08-28
HUP0003634A3 (en) 2003-04-28
SK288053B6 (sk) 2013-03-01
NO20000229L (no) 2000-01-17
DZ2564A1 (fr) 2003-02-15
EA200000141A1 (ru) 2000-08-28
SI0998291T1 (sl) 2007-12-31
CZ302668B6 (cs) 2011-08-24
AR016768A1 (es) 2001-08-01
OA11632A (en) 2004-11-22
PE99799A1 (es) 1999-12-22
CO4940422A1 (es) 2000-07-24
TW586926B (en) 2004-05-11
KR100680667B1 (ko) 2007-02-09
CY1107745T1 (el) 2013-04-18
SK602000A3 (en) 2000-07-11
JP2005247865A (ja) 2005-09-15
UA70302C2 (uk) 2004-10-15
NO326356B1 (no) 2008-11-17
HUP0003634A2 (hu) 2001-07-30
JP2001510158A (ja) 2001-07-31
NZ501256A (en) 2002-09-27

Similar Documents

Publication Publication Date Title
CA2296653C (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
AP1287A (en) Treatment of diabetes with rosiglitazone and insulin.
EP0998291B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
EP0999845B1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
WO1999003478A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20020028768A1 (en) Treatment of diabetes with rosiglitazone and insulin
US20020045649A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
HK1029272B (zh) 用噻唑烷二酮和磺酰脲治疗糖尿病
AU783539B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030092750A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
HK1028200B (zh) 用噻唑烷二酮和磺酰眼脲治疗糖尿病的方法
HK1028550B (zh) 用噻唑烷二酮、胰岛素促分泌素和双胍治疗糖尿病的方法
HK1091393A (zh) 用噻唑烷二酮和磺脲治疗糖尿病
NZ518076A (en) 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (BRL49653) for treating non-insulin dependent diabetes (NIDDM)
AU1552102A (en) Treatment of diabetes with rosiglitazone and insulin
HK1028193A1 (zh) 用噻唑烷二酮和偏甲酸精治療糖尿病
HK1028193B (zh) 用噻唑烷二酮和偏甲酸精治疗糖尿病

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20180715